Back

PR interval prolongation as intermediate phenotype for atrial fibrillation: Association with echocardiographic parameters and biomarkers (the LIFE-Adult-Study)

18 March 2018 (14:27 - 14:36)
Organised by:
Congress Presentation Part of: What is new in atrial fibrillation? Disease Modeling in Atrial Fibrillation EHRA Premium Access EHRA 2018

About the speaker

Photo
Associate Professor Jelena Kornej

Boston University, Boston (United States of America)

9 More presentations in this session

Presentation thumbnail
Recurrence rate of atrial fibrillation after the first clinical episode: A prospective evaluation using continuous cardiac rhythm monitoring.
Doctor P. Papakonstantinou (Dublin, IE)
Slides Video
Presentation thumbnail
Aetiology-dependent atrial remodelling - a translational approach to characterise disease specific atrial cardiomyopathies in arterial hypertension and diabetic mellitus
Doctor A. Bukowska (Magdeburg, DE)
Abstract Slides Video
Presentation thumbnail
Baseline echocardiography-indicated impaired atrial function predicts reoccurrence and thromboembolic risks after catheter ablation of atrial fibrillation
Doctor S. Chu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Trends in hospital admissions for atrial fibrillation in Australia: a relentless rise
Ms C. Gallagher (Adelaide, AU)
Abstract
Presentation thumbnail
An integrated AF-Clinic reduces all-cause mortality in patients with atrial fibrillation
Doctor J. Hendriks (Maastricht, NL)
Abstract

Access the full session

Session thumbnail
What is new in atrial fibrillation?

The Event

Event poster

EHRA 2018

18 March 2018 14:27 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources